Related references
Note: Only part of the references are listed.The Unconventional Role for Gastric Volume in the Response to Bariatric Surgery for Both Weight Loss and Glucose Lowering
Simon S. Evers et al.
ANNALS OF SURGERY (2020)
Epidemiology of chronic liver diseases in the USA in the past three decades
Zobair M. Younossi et al.
GUT (2020)
Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time
Pieter de Groot et al.
GUT (2020)
Laparoscopic Sleeve Gastrectomy on the Horizon as a Promising Treatment Modality for NAFLD
Mohamed Abdalla Salman et al.
OBESITY SURGERY (2020)
Impact of sleeve gastrectomy and Roux-en-Y gastric bypass on biopsy-proven non-alcoholic fatty liver disease
Deepa V. Cherla et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2020)
Changes in Gut Microbiota Composition after Bariatric Surgery: a New Balance to Decode
Silvia Palmisano et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2020)
Intestinal sensing and handling of dietary lipids in gastric bypass-operated patients and matched controls
Christoffer Martinussen et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2020)
Sleeve gastrectomy enhances glucose utilization and remodels adipose tissue independent of weight loss
David A. Harris et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2020)
Nonalcoholic Fatty Liver Disease 2020: The State of the Disease
Thomas G. Cotter et al.
GASTROENTEROLOGY (2020)
Alterations of Serum Uric Acid Level and Gut Microbiota After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy in a Hyperuricemic Rat Model
Cunlong Lu et al.
OBESITY SURGERY (2020)
Gut Microbiota Profile of Obese Diabetic Women Submitted to Roux-en-Y Gastric Bypass and Its Association with Food Intake and Postoperative Diabetes Remission
Karina Al Assal et al.
NUTRIENTS (2020)
Clinical Practice Guidelines for the Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures-2019 Update: Cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic and Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists
Jeffrey Mechanick et al.
OBESITY (2020)
Major microbiota dysbiosis in severe obesity: fate after bariatric surgery
Judith Aron-Wisnewsky et al.
GUT (2019)
Postprandial Nutrient Handling and Gastrointestinal Hormone Secretion After Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy
Maria S. Svane et al.
GASTROENTEROLOGY (2019)
Effect of Bariatric Surgery on Serum Inflammatory Factors of Obese Patients: a Systematic Review and Meta-Analysis
Moein Askarpour et al.
OBESITY SURGERY (2019)
Plasma FGF-19 Levels are Increased in Patients with Post-Bariatric Hypoglycemia
Christopher M. Mulla et al.
OBESITY SURGERY (2019)
Bile acid changes after metabolic surgery are linked to improvement in insulin sensitivity
S. Ahlin et al.
BRITISH JOURNAL OF SURGERY (2019)
Systematic review and meta-analysis of Roux-en-Y gastric bypass against laparoscopic sleeve gastrectomy for amelioration of NAFLD using four criteria
Dustin Baldwin et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2019)
Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta-analysis
Yung Lee et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis
Adriana Carino et al.
FASEB JOURNAL (2019)
Role of Bile Acids and GLP-1 in Mediating the Metabolic Improvements of Bariatric Surgery
Vance L. Albaugh et al.
GASTROENTEROLOGY (2019)
Bariatric Surgery Alters microRNA Content of Circulating Exosomes in Patients with Obesity
Yun-Ui Bae et al.
OBESITY (2019)
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Zobair M. Younossi et al.
LANCET (2019)
Changes in Blood microRNA Expression and Early Metabolic Responsiveness 21 Days Following Bariatric Surgery
Stephen L. Atkin et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Gastric bypass versus sleeve gastrectomy in patients with type 2 diabetes (Oseberg): a single-centre, triple-blind, randomised controlled trial
Dag Hofso et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Metabolic Effects of Bile Acids: Potential Role in Bariatric Surgery
Charles R. Flynn et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2019)
Intestine-Specific Overexpression of LDLR Enhances Cholesterol Excretion and Induces Metabolic Changes in Male Mice
Luca Meoli et al.
ENDOCRINOLOGY (2019)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
Yan Zheng et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism
Preeti Pathak et al.
HEPATOLOGY (2018)
Trends in Obesity and Severe Obesity Prevalence in US Youth and Adults by Sex and Age, 2007-2008 to 2015-2016
Craig M. Hales et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Increased Bile Acids and FGF19 After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass Correlate with Improvement in Type 2 Diabetes in a Randomized Trial
Reza Nemati et al.
OBESITY SURGERY (2018)
FOOD INTAKE AND EATING BEHAVIOR AFTER BARIATRIC SURGERY
Werd Al-Najim et al.
PHYSIOLOGICAL REVIEWS (2018)
Targeting FXR and FGF19 to Treat Metabolic DiseasesLessons Learned From Bariatric Surgery
Nadejda Bozadjieva et al.
DIABETES (2018)
Gut adaptation after metabolic surgery and its influences on the brain, liver and cancer
Piriyah Sinclair et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Metabolic surgery for the treatment of type 2 diabetes in obese individuals
David E. Cummings et al.
DIABETOLOGIA (2018)
TGR5 contributes to glucoregulatory improvements after vertical sleeve gastrectomy in mice
Anne K. McGavigan et al.
GUT (2017)
Circulating Adipocyte-Derived Exosomal MicroRNAs Associated with Decreased Insulin Resistance After Gastric Bypass
Monica J. Hubal et al.
OBESITY (2017)
Alterations of Gut Microbiota After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy in Sprague-Dawley Rats
Yikai Shao et al.
OBESITY SURGERY (2017)
Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism
Preeti Pathak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Bile acids and bariatric surgery
Vance L. Albaugh et al.
MOLECULAR ASPECTS OF MEDICINE (2017)
Adipose-derived circulating miRNAs regulate gene expression in other tissues
Thomas Thomou et al.
NATURE (2017)
Weight and Metabolic Outcomes 12 Years after Gastric Bypass
Ted D. Adams et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Health Effects of Overweight and Obesity in 195 Countries over 25 Years
Ashkan Afshin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Bile Diversion in Roux-en-Y Gastric Bypass Modulates Sodium-Dependent Glucose Intestinal Uptake
Gregory Baud et al.
CELL METABOLISM (2016)
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
Annika Wahlstrom et al.
CELL METABOLISM (2016)
Differences in Alimentary Glucose Absorption and Intestinal Disposal of Blood Glucose After Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy
Jean-Baptiste Cavin et al.
GASTROENTEROLOGY (2016)
Vertical sleeve gastrectomy activates GPBAR-1/TGR5 to sustain weight loss, improve fatty liver, and remit insulin resistance in mice
Lili Ding et al.
HEPATOLOGY (2016)
Roux-en-Y Gastric Bypass and Vertical Banded Gastroplasty InduceLong-Term Changes on the Human Gut Microbiome Contributing to Fat Mass Regulation
Valentina Tremaroli et al.
CELL METABOLISM (2015)
Surgery-Induced Weight Loss Is Associated With the Downregulation of Genes Targeted by MicroRNAs in Adipose Tissue
Francisco J. Ortega et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Brent A. Neuschwander-Tetri et al.
LANCET (2015)
Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance
Sungsoon Fang et al.
NATURE MEDICINE (2015)
Proteobacteria: microbial signature of dysbiosis in gut microbiota
Na-Ri Shin et al.
TRENDS IN BIOTECHNOLOGY (2015)
Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction
Changtao Jiang et al.
NATURE COMMUNICATIONS (2015)
Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
Changtao Jiang et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
FXR is a molecular target for the effects of vertical sleeve gastrectomy
Karen K. Ryan et al.
NATURE (2014)
Gut microbiota after gastric bypass in human obesity: increased richness and associations of bacterial genera with adipose tissue genes
Ling-Chun Kong et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2013)
Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice
Matthew J. Potthoff et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2013)
Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist
Sama I. Sayin et al.
CELL METABOLISM (2013)
Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Sunder Mudaliar et al.
GASTROENTEROLOGY (2013)
Richness of human gut microbiome correlates with metabolic markers
Emmanuelle Le Chatelier et al.
NATURE (2013)
Mechanisms underlying weight loss after bariatric surgery
Alexander D. Miras et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Reprogramming of Intestinal Glucose Metabolism and Glycemic Control in Rats After Gastric Bypass
Nima Saeidi et al.
SCIENCE (2013)
Conserved Shifts in the Gut Microbiota Due to Gastric Bypass Reduce Host Weight and Adiposity
Alice P. Liou et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR
Anna C. Calkin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Farnesoid X Receptor Deficiency Improves Glucose Homeostasis in Mouse Models of Obesity
Janne Prawitt et al.
DIABETES (2011)
Weight-Independent Changes in Blood Glucose Homeostasis After Gastric Bypass or Vertical Sleeve Gastrectomy in Rats
Adam P. Chambers et al.
GASTROENTEROLOGY (2011)
Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk
Jia V. Li et al.
GUT (2011)
Lowering Bile Acid Pool Size with a Synthetic Farnesoid X Receptor (FXR) Agonist Induces Obesity and Diabetes through Reduced Energy Expenditure
Mitsuhiro Watanabe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Bile Salt Sequestration Induces Hepatic De Novo Lipogenesis Through Farnesoid X Receptor- and Liver X Receptorα-Controlled Metabolic Pathways in Mice
Hilde Herrema et al.
HEPATOLOGY (2010)
TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
Charles Thomas et al.
CELL METABOLISM (2009)
Adipose Tissue Exosome-Like Vesicles Mediate Activation of Macrophage-Induced Insulin Resistance
Zhong-bin Deng et al.
DIABETES (2009)
Human gut microbiota in obesity and after gastric bypass
Husen Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells
Verena Keitel et al.
HEPATOLOGY (2007)
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
M Watanabe et al.
NATURE (2006)
Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice
YQ Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Identification of membrane-type receptor for bile acids (M-BAR)
T Maruyama et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis
CJ Sinal et al.
CELL (2000)
Share Paper
